Gentian Diagnostics ASA (OSL:GENT)

Norway flag Norway · Delayed Price · Currency is NOK
46.00
-1.00 (-2.13%)
Mar 12, 2025, 1:39 PM CET
19.79%
Market Cap 715.60M
Revenue (ttm) 152.07M
Net Income (ttm) 45.29M
Shares Out 15.42M
EPS (ttm) 2.87
PE Ratio 16.17
Forward PE 26.00
Dividend 0.40 (0.86%)
Ex-Dividend Date n/a
Volume 2,810
Average Volume 4,606
Open 46.00
Previous Close 47.00
Day's Range 46.00 - 46.20
52-Week Range 34.80 - 61.00
Beta 0.52
RSI 47.09
Earnings Date Feb 12, 2025

About Gentian Diagnostics ASA

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research worldwide. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a glomerular filtration rate marker for the diagnosis and therapeutic control of renal function; Gentia... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 58
Stock Exchange Oslo Børs
Ticker Symbol GENT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.